BONESUPPORT CEO Emil Billbäck Shares Insights About Cerament G, the New Bone Void Filler Launching in the US
XTalks
JUNE 1, 2022
Xtalks learned more about BONESUPPORT and its first FDA-approved drug-device combination product Cerament G through an email interview with BONESUPPORT’s CEO Emil Billbäck. Professor Lidgren is a well renowned orthopedic clinician, researcher and scientist. Read on to learn more! Please tell us about BONESUPPORT.
Let's personalize your content